Top 5 Takeaways Increased Risk: Children with heart conditions are at higher risk for infective endocarditis from oral bacteria. Preventive Care Disparities: 83% of children with heart conditions received preventive
Blog
Top 5 Takeaways Omicron Surge: COVID-19–associated hospitalization rates among children and adolescents increased rapidly in late December 2021 with the emergence of the Omicron variant, particularly among children aged 0–4
Top 5 Takeaways Limited Transmission: Despite the presence of multiple SARS-CoV-2 variants, there was no evidence of widespread transmission among the highly vaccinated attendees. Preventive Measures: The implementation of vaccination
Top 5 Takeaways Maternal Vaccination Effectiveness: The effectiveness of maternal completion of a 2-dose primary mRNA COVID-19 vaccination series during pregnancy against COVID-19 hospitalization among infants aged
Top 5 Takeaways Higher Effectiveness After Third Dose: Vaccine effectiveness (VE) against COVID-19-associated emergency department/urgent care (ED/UC) visits and hospitalizations was higher after the third dose compared to the second
Top 5 Takeaways Less Frequent Reactions: Local and systemic reactions were less frequent after a homologous COVID-19 mRNA vaccine booster dose compared to the second primary dose. Myocarditis Rare: Myocarditis
Top 5 Takeaways Updated Recommendations: The 2022 adult immunization schedule includes new or updated ACIP recommendations for hepatitis B, influenza, pneumococcal, recombinant zoster, and COVID-19 vaccines. Appendix Addition: An appendix
Discover the Perfect Care Facility in Ireland with Our Innovative Locator Tool: HSE Care Specialty Finder What is HSE Care Specialty Finder? Navigating the complexities of finding the right care
Top 5 Takeaways High Attack Rates: The attack rate among convention attendees was 70%, but lower among their household members (33%). Booster Dose Effectiveness: Fewer infections were observed among vaccinated
Top 5 Takeaways Updated Immunization Schedule: The 2022 schedule includes several changes from the 2021 version, with new recommendations for influenza, dengue, and COVID-19 vaccines. New Appendix: A newly created